TREATMENT STRATEGIES FOR SPINAL MUSCULAR ATROPHY

被引：4

作者：

Fuller, Heidi R. ^{[1
,2
]}

Barisic, Marija ^{[3
]}

Seso-Simic, Durdica ^{[4
]}

Speljko, Tea ^{[5
]}

Morris, Glenn E. ^{[1
,2
]}

Simic, Goran ^{[5
]}

机构：

[1] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England

[2] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England

[3] Univ Hosp Ctr Zagreb, Dept Ophthalmol, Zagreb, Croatia

[4] Zagreb E Med Ctr, Dept Paediat, Zagreb, Croatia

[5] Univ Zagreb, Sch Med, Dept Neurosci, Croatian Inst Brain Res, Zagreb 41001, Croatia

来源：

TRANSLATIONAL NEUROSCIENCE | 2010年 / 1卷 / 04期

关键词：

Clinical trials; Spinal muscular atrophy; SMN1; gene; SMN2; SMN protein; Treatment; Therapy; SURVIVAL MOTOR-NEURON; THYROTROPIN-RELEASING-HORMONE; SMN2; GENE-EXPRESSION; PLACEBO-CONTROLLED TRIAL; VALPROIC ACID INCREASES; SURROGATE END-POINTS; SEVERE MOUSE MODEL; STEM-CELLS; MESSENGER-RNA; IN-VITRO;

D O I：

10.2478/v10134-010-0045-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Progress in understanding the genetic basis and pathophysiology of spinal muscular atrophy (SMA), along with continuous efforts in finding a way to increase survival motor neuron (SMN) protein levels have resulted in several strategies that have been proposed as potential directions for efficient drug development. Here we provide an overview on the current status of the following approaches: 1) activation of SMN2 gene and increasing full length SMN2 transcript level, 2) modulating SMN2 splicing, 3) stabilizing SMN mRNA and SMN protein, 4) development of neurotrophic, neuroprotective and anabolic compounds and 5) stem cell and gene therapy. The new preclinical advances warrant a cautious optimism for emergence of an effective treatment in the very near future.

引用

页码：308 / 321

页数：14

共 157 条

[131] Therapeutics Development for Spinal Muscular Atrophy [J].

Sumner C.J. .

NeuroRX, 2006, 3 (2) :235-245

[132] Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice [J].

Sumner, Charlotte J. ;

Wee, Claribel D. ;

Warsing, Leigh C. ;

Choe, Dong W. ;

Ng, Andrew S. ;

Lutz, Cathleen ;

Wagner, Kathryn R. .

HUMAN MOLECULAR GENETICS, 2009, 18 (17) :3145-3152

[133] Valproic acid increases SMN levels in spinal muscular atrophy patient cells [J].

Sumner, CJ ;

Huynh, TN ;

Markowitz, JA ;

Perhac, JS ;

Hill, B ;

Coovert, DD ;

Schussler, K ;

Chen, XC ;

Jarecki, J ;

Burghes, AHM ;

Taylor, JP ;

Fischbeck, KH .

ANNALS OF NEUROLOGY, 2003, 54 (05) :647-654

[134] Perspectives on clinical trials in spinal muscular atrophy [J].

Swoboda, Kathryn J. ;

Kissel, John T. ;

Crawford, Thomas O. ;

Bromberg, Mark B. ;

Acsadi, Gyula ;

D'Anjou, Guy ;

Krosschell, Kristin J. ;

Reyna, Sandra P. ;

Schroth, Mary K. ;

Scott, Charles B. ;

Simard, Louise R. .

JOURNAL OF CHILD NEUROLOGY, 2007, 22 (08) :957-966

[135] SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy [J].

Swoboda, Kathryn J. ;

Scott, Charles B. ;

Crawford, Thomas O. ;

Simard, Louise R. ;

Reyna, Sandra P. ;

Krosschell, Kristin J. ;

Acsadi, Gyula ;

Elsheik, Bakri ;

Schroth, Mary K. ;

D'Anjou, Guy ;

LaSalle, Bernard ;

Prior, Thomas W. ;

Sorenson, Susan L. ;

Maczulski, Jo Anne ;

Bromberg, Mark B. ;

Chan, Gary M. ;

Kissel, John T. .

PLOS ONE, 2010, 5 (08)

[136] Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy [J].

Swoboda, Kathryn J. ;

Scott, Charles B. ;

Reyna, Sandra P. ;

Prior, Thomas W. ;

LaSalle, Bernard ;

Sorenson, Susan L. ;

Wood, Janine ;

Acsadi, Gyula ;

Crawford, Thomas O. ;

Kissel, John T. ;

Krosschell, Kristin J. ;

D'Anjou, Guy ;

Bromberg, Mark B. ;

Schroth, Mary K. ;

Chan, Gary M. ;

Elsheikh, Bakri ;

Simard, Louise R. .

PLOS ONE, 2009, 4 (05)

[137] EFFICACY OF THYROTROPIN-RELEASING-HORMONE IN THE TREATMENT OF SPINAL MUSCULAR-ATROPHY [J].

TAKEUCHI, Y ;

MIYANOMAE, Y ;

KOMATSU, H ;

OOMIZONO, Y ;

NISHIMURA, A ;

OKANO, S ;

NISHIKI, T ;

SAWADA, T .

JOURNAL OF CHILD NEUROLOGY, 1994, 9 (03) :287-289

[138] Creatine monohydrate increases strength in patients with neuromuscular disease [J].

Tarnopolsky, M ;

Martin, J .

NEUROLOGY, 1999, 52 (04) :854-857

[139] Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy [J].

Taylor, JE ;

Thomas, NH ;

Lewis, CM ;

Abbs, SJ ;

Rodrigues, NR ;

Davies, KE ;

Mathew, CG .

EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (05) :467-474

[140] Structure-function studies for the panacea, valproic acid [J].

Terbach, Nicole ;

Williams, Robin S. B. .

BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 :1126-1132

← 7 8 9 10 11 12 13 14 15 16 →